SCHEMBL20733019

SCHEMBL20733019

CN(C)C(=O)C1CN(c2cnc3cncc(-c4ccc(C(=O)O)cc4)c3c2)C1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CCNC P24863 7/20 0.40
CDK8 P49336 7/20 0.40
MELK Q14680 2/20 0.40
CHEK1 O14757 2/20 0.38
GPR119 Q8TDV5 1/20 0.38
SLC22A12 Q96S37 1/20 0.35
CYP2D6 P10635 2/20 0.35
TSHR P16473 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP46A1 Q9Y6A2 2/20 0.35
CLK4 Q9HAZ1 2/20 0.35
ADH5 P11766 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP2C9 P11712 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20733016 0.89 MELK (0.42) CCNCCDK8MELKGPR119CYP2D6
SCHEMBL22113717 0.87 CCNC (0.37) CCNCCDK8MELKGPR119CYP2D6
SCHEMBL20732975 0.86 CHEK1 (0.42) CCNCCDK8CHEK1GPR119
SCHEMBL20732892 0.69 CCNC (0.49) CCNCCDK8
SCHEMBL20733081 0.68 HPGD (0.48) CCNCCDK8MAPK1
SCHEMBL20732932 0.67 CCNC (0.57) CCNCCDK8CHEK1
SCHEMBL16432643 0.66 MAP4K4 (0.48) SLC22A12TSHRALDH1A1
SCHEMBL20732965 0.65 CCNC (0.54) CCNCCDK8
SCHEMBL22070452 0.62 CCNC (0.48) CCNCCDK8
SCHEMBL20733015 0.60 SGK1 (0.46) ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3666770-A1 NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS Joint Stock Company "Biocad" (RU) 2020-06-17 EP disclosed
WO-2019031990-A1 NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS ЗАКРЫТОЕ АКЦИОНЕРНОЕ ОБЩЕСТВО "БИОКАД" 2019-02-14 WO disclosed